lasers, Todays PR most likely changed your mind? A 20/100 patient still has hope that a new safe treatment will come along to help restore vision. The FDA will not risk an unknown treatment at this time. Not likely for the current Phase 1/2 trial. Unless you have a link, the FDA does not normally change protocol requirements once the trial has begun. The Phase 1/2 is primarily a safety trial.